Zivo Bioscience Valuation

ZIVODelisted Stock  USD 1.10  0.08  6.78%   
Today, the company appears to be overvalued. Zivo Bioscience maintains a prevalent Real Value of $1.05 per share. The last-minute price of the company is $1.1. Our model calculates the value of Zivo Bioscience from examining the company fundamentals such as Return On Asset of -1.65, shares outstanding of 1.82 M, and Operating Margin of (133.25) % as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors encourage obtaining undervalued securities and abandoning overvalued securities since, at some point, asset prices and their ongoing real values will grow together.
Overvalued
Today
1.10
Please note that Zivo Bioscience's price fluctuation is very steady at this time. Calculation of the real value of Zivo Bioscience is based on 3 months time horizon. Increasing Zivo Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Zivo Bioscience is useful when determining the fair value of the Zivo stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Zivo Bioscience. Since Zivo Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zivo Stock. However, Zivo Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.1 Real  1.05 Hype  1.1
The real value of Zivo Stock, also known as its intrinsic value, is the underlying worth of Zivo Bioscience Company, which is reflected in its stock price. It is based on Zivo Bioscience's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Zivo Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Zivo Bioscience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.04
Real Value
1.21
Upside
Estimating the potential upside or downside of Zivo Bioscience helps investors to forecast how Zivo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zivo Bioscience more accurately as focusing exclusively on Zivo Bioscience's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
1.101.101.10
Details

Zivo Bioscience Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Zivo Bioscience's current stock value. Our valuation model uses many indicators to compare Zivo Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zivo Bioscience competition to find correlations between indicators driving Zivo Bioscience's intrinsic value. More Info.
Zivo Bioscience is rated first in price to earning category among related companies. It is rated first in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Zivo Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Zivo Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zivo Bioscience's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Zivo Bioscience's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Zivo Bioscience and how it compares across the competition.

About Zivo Bioscience Valuation

The delisted stock valuation mechanism determines the current worth of Zivo Bioscience on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Zivo Bioscience. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Zivo Bioscience based exclusively on its fundamental and basic technical indicators. By analyzing Zivo Bioscience's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Zivo Bioscience's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zivo Bioscience. We calculate exposure to Zivo Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Zivo Bioscience's related companies.
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan. Zivo Bioscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.

8 Steps to conduct Zivo Bioscience's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Zivo Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Zivo Bioscience's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Zivo Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Zivo Bioscience's revenue streams: Identify Zivo Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Zivo Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Zivo Bioscience's growth potential: Evaluate Zivo Bioscience's management, business model, and growth potential.
  • Determine Zivo Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Zivo Bioscience's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Zivo Bioscience Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Zivo Bioscience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding1.6 M
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in Zivo Stock

If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Managers
Screen money managers from public funds and ETFs managed around the world